Sanofi's Q1 Earnings, Revenue Rise; 2025 Guidance Confirmed

MT Newswires Live
04-24

Sanofi (SNY) reported Q1 earnings Thursday of 1.79 euros ($2.04) per share, up from 1.53 euros a year earlier.

Revenue for the quarter ended March 31 was 9.90 billion euros, compared with 8.93 billion euros a year earlier.

Analysts polled by FactSet expected 9.95 billion euros.

The company reaffirmed its 2025 business EPS guidance of a low double-digit percentage growth at current exchange rate. It also maintained sales guidance to grow by a mid-to-high single-digit percentage at current exchange rate. Analysts polled by FactSet expect 44.97 billion euros.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10